Core Viewpoint - UBS report indicates that MicroPort Scientific Corporation-B (02252) achieved a 77% year-on-year revenue increase in the first half, surpassing the company's earlier forecast median growth rate [1] - The net loss narrowed to 113 million RMB, better than the profit forecast, while the gross margin decreased by 6 percentage points to 41% [1] - As of June 30, the company held cash of 812 million RMB [1] Revenue and Growth - MicroPort did not update its revenue guidance for the year, but UBS believes that overseas growth may continue to outpace domestic growth [1] - The company’s revenue growth of 77% indicates strong performance compared to previous expectations [1] Financial Performance - The net loss of 113 million RMB represents an improvement over prior profit forecasts, indicating better-than-expected financial health [1] - The decrease in gross margin to 41% suggests potential challenges in maintaining profitability despite revenue growth [1] Market Outlook - UBS maintains a cautious stance on bidding and competition in China, reflecting concerns about the domestic market environment [1] - The target price for the stock has been lowered from 23.2 HKD to 21.4 HKD, indicating a more conservative outlook [1]